Immunwork

    OverviewSuggest Edit

    Immunwork is a company that researches, develops, and commercializes drugs for cancer treatment with a focus on immunology. It uses a proprietary technology platform to create T-E pharmaceuticals that contain both targeting (T) and effector (E) moieties. The technology can be used for constructing antibody-drug conjugates (ADCs), bispecific antibodies, multivalent antibodies, and other pharmaceutical configurations. The company aims to develop medications for conditions such as cancer, autoimmune diseases, osteoporosis, infectious, and central nervous system diseases, pathological blood clots, and rejection reactions in organ transplantation.
    TypePrivate
    Founded2014
    HQTW
    Websiteimmunwork.com

    Locations

    Immunwork is headquartered in
    Taiwan

    Location Map

    Latest Updates

    Employees (est.) (Mar 2020)12
    Cybersecurity ratingBMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Immunwork Office Locations

    Immunwork has an office in
    Show all (1)

    Immunwork Financials and Metrics

    Summary Metrics

    Founding Date

    2014

    Immunwork Cybersecurity Score

    Cybersecurity ratingPremium dataset

    B

    85/100

    SecurityScorecard logo

    Immunwork Online and Social Media Presence

    Embed Graph

    Immunwork Frequently Asked Questions

    • When was Immunwork founded?

      Immunwork was founded in 2014.

    • How many employees does Immunwork have?

      Immunwork has 12 employees.

    • Who are Immunwork competitors?

      Competitors of Immunwork include Takeda Oncology, Shanghai Junshi Biosciences and Ethypharm.

    • Where are Immunwork offices?

      Immunwork has an office in.

    • How many offices does Immunwork have?

      Immunwork has 1 office.